Home
>
National Drug Code (NDC)
>
ZEOSA
ZEOSA - 0093-2090-58 - (norethindrone and ethinyl estradiol, and ferrous fumarate)
Drug Information of ZEOSA
| Product NDC: | 0093-2090 |
| Proprietary Name: | ZEOSA |
| Non Proprietary Name: | norethindrone and ethinyl estradiol, and ferrous fumarate |
| Active Ingredient(s): | & nbsp; norethindrone and ethinyl estradiol, and ferrous fumarate |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZEOSA
| Product NDC: | 0093-2090 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078965 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110325 |
Package Information of ZEOSA
| Package NDC: | 0093-2090-58 |
| Package Description: | 3 POUCH in 1 CARTON (0093-2090-58) > 1 BLISTER PACK in 1 POUCH (0093-2090-28) > 1 KIT in 1 BLISTER PACK |
NDC Information of ZEOSA
| NDC Code | 0093-2090-58 |
| Proprietary Name | ZEOSA |
| Package Description | 3 POUCH in 1 CARTON (0093-2090-58) > 1 BLISTER PACK in 1 POUCH (0093-2090-28) > 1 KIT in 1 BLISTER PACK |
| Product NDC | 0093-2090 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | norethindrone and ethinyl estradiol, and ferrous fumarate |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20110325 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
